ClinicaSpace.com
Clinical Research
News & Careers
 
Search the Site
    
 
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login   

By Industry | By Industry Segment | By Services and Suppliers | By Location | Profile Search
 Company Profile

 

Celldex Therapeutics, Inc. 

222 Cameron Drive
Suite 400
Phillipsburg  New Jersey  08865  U.S.A.
Phone: 908-454-7120 Fax: 908-454-1911


SEARCH JOBS


Industry
Biotechnology






 Company News
Celldex (CLDX) Prices Public Offering Of Common Stock 2/26/2015 1:17:24 PM
Celldex (CLDX) Announces Proposed Public Offering Of Common Stock 2/25/2015 7:48:34 AM
Celldex (CLDX) Reports Fourth Quarter And Year-End 2014 Results 2/24/2015 10:34:29 AM
Celldex (CLDX)'s Rindopepimut (Rintega) Receives FDA Breakthrough Therapy Designation For The Treatment Of Adult Patients With Egfrviii-Positive Glioblastoma 2/23/2015 9:33:25 AM
Celldex (CLDX)'s Rindopepimut Deemed a Breakthrough By the FDA 2/23/2015 7:27:38 AM
Celldex Therapeutics, Inc. (CLDX) To Report Fourth Quarter And Fiscal 2014 Business/Financial Results And Host 2015 Corporate Strategy Conference Call 2/20/2015 7:32:56 AM
Celldex Therapeutics, Inc. (CLDX) Announces Upcoming Presentation At The 2015 Leerink Global Healthcare Conference 2/9/2015 7:45:21 AM
Celldex Therapeutics, Inc. (CLDX) And Bristol-Myers Squibb Company (BMY) Announce Initiation Of Phase 1/2 Combination Study Of Varlilumab And Opdivo® In Advanced Refractory Solid Tumors 1/29/2015 7:36:47 AM
Celldex Therapeutics, Inc. (CLDX) Announces Appointment To Board Of Directors 12/18/2014 7:58:42 AM
Celldex Therapeutics, Inc. (CLDX) Announces Completion Of Enrollment In Phase 3 Study Of Rindopepimut In Frontline Glioblastoma 12/16/2014 7:37:02 AM
12345678910...